Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1997 May;76(3):F163–F167. doi: 10.1136/fn.76.3.f163

Neonatal symptomatic thromboembolism in Germany: two year survey

U Nowak-Gottl, R von Kries, U Gobel
PMCID: PMC1720641  PMID: 9175945

Abstract

AIMS—To determine the incidence of neonatal thromboembolism in Germany.
METHODS—Diagnostic imaging techniques, therapeutic modalities, and short term outcome were evaluated in a prospective nationwide two year case registry study.
RESULTS—The reported incidence of symptomatic neonatal thromboembolism, diagnosed in most cases with Doppler ultrasonography, was 5.1 per 100 000 births, with a total of 79 cases registered: renal venous thrombosis (n=35); venous thrombosis (n=25); and arterial vascular occlusion (n=19). Fifty seven of 79 thromboses were associated with additional risk factors (central line n=25, asphyxia n=13, septicaemia n=11, dehydration n=6, maternal diabetes n=2, cardiac disease n=1). Inherited thrombophilia was also diagnosed in seven out of 35 cases investigated. Twenty three children received supportive treatment: 42 received heparin and in 13 neonates thrombolytic agents were administered. Most neonates (91%) survived; seven died.
CONCLUSION—Controlled multicentre studies are needed to obtain more information on treatment efficacy.

 Keywords: thromboembolism; Doppler ultrasonography; heparin; thrombolytic agents; Germany

Full Text

The Full Text of this article is available as a PDF (128.1 KB).

Figure 1  .

Figure 1  

Open in a new tab

Different age distribution at time of diagnosis in renal venous thrombosis (RVT), venous thrombosis (VT), and arterial vascular occlusion (AT) in preterm or term neonates (median and SE values). Compared with preterm babies, term infants developed RVT (P= 0.002) or AT significantly earlier (P=0.009).

Figure 2  .

Figure 2  

Open in a new tab

Treatment modalities of neonatal thromboembolism for arterial and venous sites.

Figure 3  .

Figure 3  

Open in a new tab

Patency of neonatal thromboembolism according to arterial and venous sites.

Figure 4  .

Figure 4  

Open in a new tab

Patency of neonatal thromboembolism according to different treatment modalities.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost. 1995 Jul;74(1):415–425. [PubMed] [Google Scholar]
  2. Andrew M., Paes B., Johnston M. Development of the hemostatic system in the neonate and young infant. Am J Pediatr Hematol Oncol. 1990 Spring;12(1):95–104. doi: 10.1097/00043426-199021000-00019. [DOI] [PubMed] [Google Scholar]
  3. Andrew M., Vegh P., Johnston M., Bowker J., Ofosu F., Mitchell L. Maturation of the hemostatic system during childhood. Blood. 1992 Oct 15;80(8):1998–2005. [PubMed] [Google Scholar]
  4. Arneil G. C. Renal venous thrombosis. Contrib Nephrol. 1979;15:21–29. doi: 10.1159/000402591. [DOI] [PubMed] [Google Scholar]
  5. Bassett F. H., 3rd, Lincoln C. R., King T. D., Canent R. V., Jr Inequality in the size of the lower extremity following cardiac catheterization. South Med J. 1968 Oct;61(10):1013–1017. doi: 10.1097/00007611-196810000-00001. [DOI] [PubMed] [Google Scholar]
  6. David M., Manco-Johnson M., Andrew M. Diagnosis and treatment of venous thromboembolism in children and adolescents. On behalf of the Subcommittee on Perinatal Haemostasis of the Scientific and Standardization Committee of the ISTH. Thromb Haemost. 1995 Aug;74(2):791–792. [PubMed] [Google Scholar]
  7. Engel J., Heim M., Tsur H. Late complications of neonatal Volkmann's ischaemia. Hand. 1982 Jun;14(2):162–163. doi: 10.1016/s0072-968x(82)80009-0. [DOI] [PubMed] [Google Scholar]
  8. Göbel U. Inherited or acquired disorders of blood coagulation in children with neurovascular complications. Neuropediatrics. 1994 Feb;25(1):4–7. doi: 10.1055/s-2008-1071573. [DOI] [PubMed] [Google Scholar]
  9. Jobin J., O'Regan S., Demay G., Mongeau J. G., Robitaille P. Neonatal renal vein thrombosis - long-term follow-up after conservative management. Clin Nephrol. 1982 Jan;17(1):36–40. [PubMed] [Google Scholar]
  10. Mannucci P. M., Tripodi A. Laboratory screening of inherited thrombotic syndromes. Thromb Haemost. 1987 Jun 3;57(3):247–251. [PubMed] [Google Scholar]
  11. Nowak-Göttl U., Auberger K., Göbel U., Kreuz W., Schneppenheim R., Vielhaber H., Zenz W., Zieger B. Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism. Eur J Pediatr. 1996 Nov;155(11):921–927. doi: 10.1007/BF02282879. [DOI] [PubMed] [Google Scholar]
  12. Nowak-Göttl U., Koch H. G., Aschka I., Kohlhase B., Vielhaber H., Kurlemann G., Oleszcuk-Raschke K., Kehl H. G., Jürgens H., Schneppenheim R. Resistance to activated protein C (APCR) in children with venous or arterial thromboembolism. Br J Haematol. 1996 Mar;92(4):992–998. doi: 10.1046/j.1365-2141.1996.424957.x. [DOI] [PubMed] [Google Scholar]
  13. Nuss R., Hays T., Manco-Johnson M. Childhood thrombosis. Pediatrics. 1995 Aug;96(2 Pt 1):291–294. [PubMed] [Google Scholar]
  14. Schmidt B., Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics. 1995 Nov;96(5 Pt 1):939–943. [PubMed] [Google Scholar]
  15. Schmidt B., Zipursky A. Thrombotic disease in newborn infants. Clin Perinatol. 1984 Jun;11(2):461–488. [PubMed] [Google Scholar]
  16. Vielhaber H., Kohlhase B., Koch H. G., Kehl H. G., Fliedner M., Kececioglu D., Kehrel B., Veltmann H., Vogt J., Nowak-Göttl U. Flush heparin during cardiac catheterisation prevents long-term coagulation activation in children without APC-resistance-preliminary results. Thromb Res. 1996 Mar 15;81(6):651–656. doi: 10.1016/0049-3848(96)00041-2. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES